BeStock  
Stocks › Biotechnology › PTCT

PTC Therapeutics PTCT

US equityMarket cap rank #2094Biotechnology
$56.42 −$1.91 (-3.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $56.99 +1.01%
Open$58.78
Prev close$58.33
Day range$56.18 – $58.96
Volume952.6K
Market cap$4.71B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership124.9%+1.65 pts vs. prior quarter
Institutions holding473+1 vs. prior quarter
Insider trades (recent)7 buys / 40 sellsNet selling
Short interest9.31% of floatDays to cover 7.5 · as of 30 Oct 2026
Short-sale volume share18.6%5-day average of daily volume

Short-sale volume as % of daily volume

12%16%21%26%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$10.11M (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$2.3MSuper−$7.8MBig−$10.3MMid−$26.6MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 47.7% of shares outstanding.

Largest holders

  • BlackRock17.23%
  • RTW Investments, LP9.27%
  • Janus Henderson Group plc8.66%
  • State Street Global Advisors6.60%
  • Vanguard Portfolio Management, LLC5.96%
  • Wellington Management Group4.94%
  • Vanguard Capital Management, LLC4.33%
  • The Toronto-Dominion Bank2.59%

By investor type

  • Mutual Fund94.78%
  • Hedge Fund19.50%
  • Public Company5.78%
  • Individual/Insider2.38%
  • Private Company2.29%
  • Government Pension Fund1.14%
  • Insurance Company0.63%
  • Endowment Fund0.49%

Reported short interest has fallen from 12.25% to 9.31% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
UBS Asset Management Mutual Fund 2026/Q3 +1,618,021 2.4%
State Street Global Advisors Mutual Fund 2026/Q3 +913,603 6.6%
BlackRock Mutual Fund 2026/Q3 +432,763 17.2%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +282,789 0.3%
Public Sector Pension Investment Board Government Pension Fund 2026/Q3 +167,226 0.5%
Boston Partners Global Investors, Inc. Mutual Fund 2026/Q3 +144,880 1.0%
Natixis S.A. Private Company 2026/Q3 +124,240 0.1%
Bessemer Investment Management LLC Mutual Fund 2026/Q3 +98,814 0.2%
Westfield Capital Management Company, L.P. Mutual Fund 2026/Q3 +1,956,156 2.3%
William Blair Investment Management, LLC Mutual Fund 2026/Q3 +1,772,610 2.1%
Fuller & Thaler Asset Management, Inc. Mutual Fund 2026/Q3 +1,156,819 1.4%
BlackRock Mutual Fund 2026/Q3 +1,015,837 16.7%
Blue Sparrow, Llc Mutual Fund 2026/Q3 +860,100 1.3%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +639,368 1.3%
Arrowstreet Capital, Limited Partnership Mutual Fund 2026/Q3 +542,750 0.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
13 Oct 2026 Michael Schmertzler Independent Chairperson Automatic Disposition -2,500 $60.14 1,450,193
8 Oct 2026 Mark Boulding Chief Legal Officer Derivative Exercise and Sale -192 $64.26 105,272
6 Oct 2026 Michael Schmertzler Independent Chairperson Automatic Disposition -2,500 $63.95 1,452,693
5 Oct 2026 Mark Boulding Chief Legal Officer Intent to Sell (Form 144) -435 $64.16 –
5 Oct 2026 Mark Boulding Chief Legal Officer Derivative Exercise and Sale -2,073 $64.16 105,272
4 Oct 2026 Mark Boulding Chief Legal Officer Intent to Sell (Form 144) -1,638 $64.03 –
29 Sep 2026 Glenn Steele Independent Director Derivative Exercise and Sale -12,000 $65.16 20,167
16 Sep 2026 Michael Schmertzler Independent Chairperson Automatic Disposition -20,000 $68.45 1,455,193
9 Sep 2026 Michael Schmertzler Independent Chairperson Automatic Disposition -20,000 $68.67 1,475,193
26 Aug 2026 Michael Schmertzler Independent Chairperson Automatic Disposition -25,000 $73.18 1,495,193
19 Aug 2026 Michael Schmertzler Independent Chairperson Automatic Disposition -25,000 $73.67 1,520,193
18 Aug 2026 Michael Schmertzler Independent Chairperson Intent to Sell (Form 144) -50,000 – –
16 Aug 2026 Mark Boulding Chief Legal Officer Derivative Exercise and Sale -2,813 $72.90 105,272
3 Aug 2026 Matthew Klein Chief Executive Officer Open Market Disposition -10,292 $68.57 156,555
27 Jul 2026 Hege Sollie-Zetlmayer Director Other Acquisition +6,000 – 31,750
27 Jul 2026 Hege Sollie-Zetlmayer Director Other Derivative Acquisition +5,213 $75.39 1,738
27 Jul 2026 Hege Sollie-Zetlmayer Director Initial Statement of Beneficial +0 – 153,875
13 Jul 2026 Pierre Gravier Chief Financial Officer Open Market Disposition -3,494 $80.35 31,111
8 Jul 2026 Neil Almstead Chief Technical Operations Officer Derivative Exercise and Sale -2,464 $90.25 16,029
8 Jul 2026 Mary Smith Independent Director Derivative Exercise and Sale -15,834 $90.00 19,480

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 7,779,250 9.3% 7.5
15 Oct 2026 8,303,282 9.9% 7.6
30 Sep 2026 9,168,333 11.0% 6.1
15 Sep 2026 9,738,919 11.7% 11.0
31 Aug 2026 9,828,154 11.8% 12.1
14 Aug 2026 10,221,046 12.2% 10.8

Discussion

No comments yet — be the first to weigh in on PTCT.

Sign in to join the discussion.

Scroll to Top